Beta Bionics, Inc. financial data

Symbol
BBNX on Nasdaq
Location
11 Hughes, Irvine, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 6, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.4M shares
Common Stock, Shares, Outstanding 43.4M shares
Common Stock, Value, Issued 4K USD
Weighted Average Number of Shares Outstanding, Basic 30.7M shares +410%
Weighted Average Number of Shares Outstanding, Diluted 30.7M shares +410%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 17.6M USD +36.4%
Research and Development Expense 7.59M USD +38.5%
Selling and Marketing Expense 13.4M USD +74.9%
General and Administrative Expense 6.62M USD +88.5%
Operating Income (Loss) -18.6M USD -97.2%
Nonoperating Income (Expense) -10M USD -234%
Net Income (Loss) Attributable to Parent -28.7M USD -130%
Earnings Per Share, Basic -0.93 USD/shares +55.1%
Earnings Per Share, Diluted -0.93 USD/shares +55.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 42.5M USD +92.3%
Accounts Receivable, after Allowance for Credit Loss, Current 9.06M USD
Inventory, Net 15.7M USD
Other Assets, Current 260K USD
Assets, Current 262M USD
Property, Plant and Equipment, Net 5.52M USD
Operating Lease, Right-of-Use Asset 6.34M USD
Other Assets, Noncurrent 146K USD
Assets 338M USD
Accounts Payable, Current 3.45M USD
Employee-related Liabilities, Current 6M USD
Liabilities, Current 16.5M USD
Operating Lease, Liability, Noncurrent 5.45M USD
Liabilities 24.3M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax 240K USD
Retained Earnings (Accumulated Deficit) -325M USD
Stockholders' Equity Attributable to Parent 314M USD
Liabilities and Equity 338M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20M USD -64.5%
Net Cash Provided by (Used in) Financing Activities 211M USD +3518550%
Net Cash Provided by (Used in) Investing Activities -179M USD -2443%
Common Stock, Shares Authorized 700M shares
Common Stock, Shares, Issued 43.4M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 42.6M USD +91.9%
Operating Lease, Liability 6.97M USD
Depreciation 303K USD +5.58%
Payments to Acquire Property, Plant, and Equipment 333K USD -18%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -28.5M USD -126%
Lessee, Operating Lease, Liability, to be Paid 8.7M USD
Property, Plant and Equipment, Gross 11.1M USD
Operating Lease, Liability, Current 1.52M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 929K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.53M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.73M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.05M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Operating Lease, Payments 400K USD +33.3%
Additional Paid in Capital 639M USD
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 2.8M USD +107%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares